Literature DB >> 20372800

Identification of UNC5A as a novel transcriptional target of tumor suppressor p53 and a regulator of apoptosis.

Yuji Miyamoto1, Manabu Futamura, Noriaki Kitamura, Yasuyuki Nakamura, Hideo Baba, Hiroufmi Arakawa.   

Abstract

UNC5A is an axon-guidance molecule, and plays a critical role in neuronal development and differentiation as a netrin-1 receptor. Emerging evidence suggests that axon guidance molecules including UNC5A regulate apoptosis in non-neuronal cells. Here, we report that UNC5A regulates apoptosis as a downstream target of p53. UNC5A expression was strongly induced by exogenous and endogenous p53. Chromatin immunoprecipitation (ChIP) revealed that p53 binds to a sequence in the promoter region of the UNC5A gene. Reporter assays showed that this sequence exhibits p53-dependent transcriptional activity. Overexpression of UNC5A significantly suppressed colony formation of two glioblastoma cell lines-U373MG and T98G. UNC5A dramatically induced apoptosis through the activation of caspase-3 in various cancer cell lines, including LS174T (colon cancer), U373MG (glioblastoma), SH-SY5Y (neuroblastoma), and SKNAS (neuroblastoma). Finally, gamma irradiation strongly induced the expression of UNC5A mRNA in the spleen and colon of p53+/+ mice, but not in those of p53-/- mice, implying that the transcription of UNC5A in vivo is regulated by p53. These results suggest that UNC5A is a novel transcriptional target of p53 and plays a role in p53-dependent apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20372800     DOI: 10.3892/ijo_00000609

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  13 in total

1.  Deleted in Colorectal Cancer (DCC) pathfinding: axon guidance gene finally turned tumor suppressor.

Authors:  Molly Duman-Scheel
Journal:  Curr Drug Targets       Date:  2012-10       Impact factor: 3.465

2.  Deleted in colorectal carcinoma suppresses metastasis in p53-deficient mammary tumours.

Authors:  Paul Krimpenfort; Ji-Ying Song; Natalie Proost; John Zevenhoven; Jos Jonkers; Anton Berns
Journal:  Nature       Date:  2012-02-22       Impact factor: 49.962

3.  MIEAP, a p53-downstream gene, is associated with suppression of breast cancer cell proliferation and better survival.

Authors:  Manabu Futamura; Yoshihisa Tokumaru; Kazuaki Takabe; Hirofumi Arakawa; Yoshimi Asano; Ryutaro Mori; Junichi Mase; Akira Nakakami; Kazuhiro Yoshida
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

4.  Overexpression of the dependence receptor UNC5H4 inhibits cell migration and invasion, and triggers apoptosis in neuroblastoma cell.

Authors:  Hong Wang; Bin Zhang; Min Gu; Shuang Li; Zuofei Chi; Liangchun Hao
Journal:  Tumour Biol       Date:  2014-02-12

5.  O-GlcNAcylation regulates EZH2 protein stability and function.

Authors:  Chi-Shuen Chu; Pei-Wen Lo; Yi-Hsien Yeh; Pang-Hung Hsu; Shih-Huan Peng; Yu-Ching Teng; Ming-Lun Kang; Chi-Huey Wong; Li-Jung Juan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

6.  DNA damage-inducible gene, UNC5A, functions as a tumor-suppressor in bladder cancer.

Authors:  Yuyan Zhu; Meng Yu; Yifu Chen; Yixia Wang; Junyong Wang; Chunming Yang; Jianbin Bi
Journal:  Tumour Biol       Date:  2014-04-16

7.  The Fanconi anemia group C protein interacts with uncoordinated 5A and delays apoptosis.

Authors:  FengFei Huang; Manel Ben Aissa; Audrey Magron; Caroline C Huard; Chantal Godin; Georges Lévesque; Madeleine Carreau
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

8.  The transcription factor p53: not a repressor, solely an activator.

Authors:  Martin Fischer; Lydia Steiner; Kurt Engeland
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Combining chemotherapeutic agents and netrin-1 interference potentiates cancer cell death.

Authors:  Andrea Paradisi; Marion Creveaux; Benjamin Gibert; Guillaume Devailly; Emeline Redoulez; David Neves; Elsa Cleyssac; Isabelle Treilleux; Christian Klein; Gerhard Niederfellner; Philippe A Cassier; Agnès Bernet; Patrick Mehlen
Journal:  EMBO Mol Med       Date:  2013-10-08       Impact factor: 12.137

Review 10.  O-GlcNAcylation, an Epigenetic Mark. Focus on the Histone Code, TET Family Proteins, and Polycomb Group Proteins.

Authors:  Vanessa Dehennaut; Dominique Leprince; Tony Lefebvre
Journal:  Front Endocrinol (Lausanne)       Date:  2014-09-26       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.